Hospira Docetaxel Injection, 120 mg/12 mL, single vial

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

docetaxel, Quantity: 10 mg/mL

MAH:

Hospira Australia Pty Ltd

INN:

Docetaxel

pharmaceutical_form:

Injection

composition:

Excipient Ingredients: citric acid; ethanol absolute; polysorbate 80; polyethylene glycol monomethyl ether

administration_route:

Intravenous Infusion

units_in_package:

1 x 15 mL vial

prescription_type:

(S1) This Schedule is intentionally blank

therapeutic_indication:

Breast cancer, Non-small cell lung cancer, Stomach cancer, Head and neck cancer, Ovarian cancer, Oesophageal cancer, Uterine cancer, Prostate cancer

leaflet_short:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

authorization_status:

Licence status A

authorization_date:

2013-10-25